Provided by Tiger Trade Technology Pte. Ltd.

Rocket Pharmaceuticals, Inc.

4.39
-0.0800-1.79%
Post-market: 4.430.0400+0.91%19:38 EDT
Volume:3.08M
Turnover:13.42M
Market Cap:475.10M
PE:-2.18
High:4.48
Open:4.40
Low:4.17
Close:4.47
52wk High:8.80
52wk Low:2.19
Shares:108.22M
Float Shares:78.79M
Volume Ratio:1.60
T/O Rate:3.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0100
EPS(LYR):-2.0100
ROE:-60.27%
ROA:-33.29%
PB:1.71
PE(LYR):-2.18

Loading ...

Jun 18, 2025

Major Issues Report

Form 8-K - Current report
May 27, 2025

Major Issues Report

Form 8-K - Current report
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2025

Major Issues Report

Form 8-K - Current report
Apr 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 07, 2025

Major Issues Report

Form 8-K - Current report
Apr 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities